Small caps: Silence Therapeutics, Eros, Interquest,...
14th Jul 2010 14:01
Silence Therapeutics has agreed a one-year extension of its ongoing research and development collaboration with AstraZeneca. The pair are working on five therapeutic molecules addressing respiratory and oncology indications. Film distributor Eros traded well in the second half of the financial year
Read moreCyprotex Experiences Strong Second Quarter
14th Jul 2010 07:35
LONDON (Dow Jones)--Cyprotex PLC (CRX.LN), a drug discovery technology and information company, said Wednesday it has experienced a strong second quarter in the current year and this momentum has continued into July. MAIN FACTS: -Company's revenue and EBITDA performance in line with market e
Read moreLondon close: Weak finish as banks retreat
18th Mar 2010 16:35
London closed in the red after a mixed opening on Wall Street as banks and miners ran into profit taking. Among the big caps, GlaxoSmithKline was the best performer, after rival drug group, Switzerland's Novartis, had to hand back US rights of a drug widely considered a generic copy of Glaxo's top
Read moreLondon afternoon: Back to square one
18th Mar 2010 15:19
A mixed opening on Wall Street has provided no guidance for a similarly rudderless London market. Among the big caps, GlaxoSmithKline is the best performer, after rival drug group, Switzerland's Novartis, had to hand back US rights of a drug widely considered a generic copy of Glaxo's top selling
Read moreLondon midday: Second liners hog the limelight
18th Mar 2010 11:54
While the FTSE 100 is becalmed most of the action is taking place in the FTSE 250 today, where a mixed bag of announcements has prompted varied share price reactions. Electronic components distributor Premier Farnell powered ahead after reporting full year sales and underlying profits for fiscal 20
Read moreLondon open: Banks lead decline
18th Mar 2010 08:26
London's top stocks have slipped back in early dealings on Thursday, with banks leading the index lower. Lloyds Banking, Barclays and Royal Bank of Scotland are the three worst performers on the Footsie, closely followed by HSBC. Bakery and sandwich chain Greggs saw full-year profits come in sligh
Read moreCyprotex rejects bid approach
18th Mar 2010 07:48
Manchester based drug discovery firm Cyprotex said it has rejected an unsolicited approach regarding a potential offer and is no longer in talks with the unnamed suitor. The group announced on 2 March that it had received a 'highly preliminary and unsolicited approach regarding a potential offer'.
Read moreCyprotex profit slips, doubles customer base
17th Mar 2010 08:52
Manchester based drug discovery firm Cyprotex reported a drop in 2009 profit but doubled the number of its strategic customers. The group, which tests drugs for big pharmaceutical companies, said operating profit fell to £0.46m for the year ended 31 December 2009 from £0.57m the year before. Annua
Read moreSmall caps round-up: Share, Jetion Solar, Futura Medical...
2nd Mar 2010 12:38
Share, parent company of retail stockbroker The Share Centre, lifted profits last year to £2.35m from £1.46m on turnover of £14.1m, up from £12m. There was a significant increase in retail investor activity - especially online with deal volumes up by 75% on 2008, Share said. The interim dividend is
Read moreSmall caps round-up: ViaLogy, Concurrent Technologies, San Leon ...
5th Jan 2010 13:45
Shares in ViaLogy jumped on news that it has signed a deal with one of the largest privately held exploration and production companies in America to provide its QuantumRD services. ViaLogy, which develops Internet Protocol (IP) based sensor networks, did not comment on the financial details of the
Read moreCyprotex hit by lower demand
20th Nov 2009 09:57
Shares in drug discovery technology and information company Cyprotex fell back after it said it had experienced lower than expected demand over the fourth quarter, including from its largest customer. However, the company did say that it had seen more business enquiries during the quarter. 'Altho
Read moreSmall caps round-up: Andor, Birmingham City, Bowleven...
12th Aug 2009 12:49
Shares in Andor Technology climbed after the digital camera manufacturer said it expects revenues and profits for the full year to exceed expectations. Shares in Birmingham City climbed by 10% after the football club confirmed it has received an approach from Grandtop, the company owned by Hong Kon
Read moreSmall caps round-up: NetDimensions, Ocean Power, Qonnectis...
14th Jul 2009 12:59
Training software provider NetDimensions traded in lien with expectations in the first half of 2009. Cash balances at the end of June stood at $6.8m, up from $5.3m at the end of 2008. The company said its cash balance is equivalent to 16.5p in cash per share, a few pence above the current share pric
Read more